Sex- and Obesity-specific Association of Aromatase (CYP19A1) Gene Variant with Apolipoprotein B and Hypertension
- 1 October 2015
- journal article
- research article
- Published by Elsevier in Archives of Medical Research
- Vol. 46 (7) , 564-571
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Associations between Aromatase CYP19 rs10046 Polymorphism and Breast Cancer Risk: From a Case-Control to a Meta-Analysis of 20,098 SubjectsPLOS ONE, 2013
- A genetic polymorphism in the CYP19A1 gene and the risk of hypertension among midlife womenMaturitas, 2012
- Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome EvaluationThe Journal of Clinical Endocrinology & Metabolism, 2008
- A Single-Nucleotide Polymorphism in the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor Letrozole in Advanced Breast CarcinomaClinical Cancer Research, 2008
- Sex and Body Mass Index Specific Regulation of Blood Pressure by CYP19A1 Gene VariantsHypertension, 2007
- Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohortsInternational Journal of Cancer, 2007
- Sex Differences of Endogenous Sex Hormones and Risk of Type 2 DiabetesJAMA, 2006
- Definition of Metabolic SyndromeCirculation, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- A tetranucleotide repeat polymorphism inCYP19 and breast cancer riskInternational Journal of Cancer, 2000